Probaclac Voyageur TD
Natural health product licensed in Canada
- Licence holder
- Les laboratoires Nicar inc.
- NPN or DIN-HM
- 80108358
- Status
- Active licence
- Licence date
- 23 February 2021
- Revision date
- 16 November 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Streptococcus salivarius subsp. thermophilus Source : En entier | 200 Millions d'UFC | Not calculated |
| Streptococcus salivarius subsp. thermophilus Source : En entier | 300 % | Not calculated |
| Streptococcus salivarius subsp. thermophilus Source : NL-231 | 200 Millions d'UFC | Not calculated |
| Streptococcus salivarius subsp. thermophilus Source : NL-231 | 300 % | Not calculated |
| Lacticaseibacillus rhamnosus Source : Cellule entière | 800 Millions d'UFC | Not calculated |
| Lacticaseibacillus rhamnosus Source : Rosell-343 | 800 Millions d'UFC | Not calculated |
| Lacticaseibacillus rhamnosus Source : Cellule entière | 300 % | Not calculated |
| Lacticaseibacillus rhamnosus Source : Rosell-343 | 300 % | Not calculated |
| Bifidobacterium breve Source : Cellule entière | 600 Millions d'UFC | Not calculated |
| Bifidobacterium breve Source : NL-240 | 600 Millions d'UFC | Not calculated |
| Vitamine C Source : Acide ascorbique | 15 mg | Not calculated |
Non-medicinal ingredients
Sucrose, Extrait de Levure, Hypromellose, Stéarate de magnésium, Maltodextrine, Trehalose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants, adolescents et adultes | minimum: 6 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Contribue à soutenir la santé intestinale/gastrointestinale. Source de probiotiques. Aide au maintien/soutien des fonctions immunitaires. Aide à réduire les risques de la diarrhée du voyageur. Fournit un confort intestinal aux voyageurs.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Ne pas utiliser ce produit si vous souffrez d'un déficit immunitaire (par ex., sida, lymphome, patients subissant un traitement prolongé aux corticostéroïdes).
- Précautions et mises en garde
Cesser l'utilisation et consulter un praticien de soins de santé/fournisseur de soins de santé/professionnel de la santé/docteur/médecin si des symptômes de troubles digestifs (par ex., diarrhée) se manifestent, s'aggravent et/ou persistent au-delà de 3 jours. Si vous souffrez de fièvre, de vomissements, de diarrhée sanglante ou de douleurs abdominales intenses, consulter un praticien de soins de santé avant d'en faire l'usage.
Source
Official Health Canada record, licence 80108358
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging